How does hematocrit influence oxygen delivery and tissue perfusion during CPB?

• A. Higher hematocrit increases viscosity with no impact on oxygen content.
• B. Higher hematocrit increases oxygen-carrying capacity but increases viscosity; lower hematocrit reduces viscosity but reduces oxygen content—trade-off.
• C. Hematocrit has no effect on oxygen delivery.
• D. Lower hematocrit always improves perfusion without any trade-offs.

Answer: (B)

The main idea is how hematocrit affects both how much oxygen the blood can carry and how easily blood can flow to tissues during CPB. Hematocrit reflects the concentration of red blood cells, so more cells mean more hemoglobin available to bind and transport oxygen, increasing oxygen content (CaO2). But more red cells also make the blood thicker, raising viscosity and vascular resistance, which can limit flow and capillary perfusion if the pump isn’t adjusted.

If hematocrit is higher, CaO2 rises, improving the oxygen-carrying capacity, but the increased viscosity can impede perfusion unless pump flow is increased. If hematocrit is lower, viscosity drops and flow can improve, enhancing tissue perfusion, but CaO2 falls because there are fewer red cells to carry oxygen. The net oxygen delivery (DO2) depends on both flow (the amount of blood reaching tissues) and CaO2, and about CPB you often see this trade-off summarized as DO2 ≈ CO × CaO2, with CaO2 ≈ Hb × 1.34 × SaO2 plus dissolved oxygen.

Thus, the best answer recognizes that higher hematocrit boosts oxygen content but raises viscosity, while lower hematocrit lowers viscosity but reduces oxygen content—there’s a balance to optimize tissue oxygen delivery during CPB.